ReviewFrontiers in pharmacology2024

Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities.

Chi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.